שם הכותב: תאריך: 24 מרץ 2014

בוב גרוסמן וברי שינדלר ירצו ב"מועדון ארוחת בוקר" של הביו רפואי

בית הספר למוסמכים במינהל עסקים, התכנית בניהול ביו רפואי מזמינים אתכם למפגש

"מועדון ארוחת בוקר" שיתקיים ביום שישי, 4.4.2014, בין השעות 7:45-9:00

בחדר 130 בניין מינהל עסקים.

 

במפגש תתקיים הרצאת אורח מאת מר בוב גרוסמן ומר ברי שינדלר בנושא: 

Recent Growth in Transactions in the Israeli Life Science and

Agriculture Markets – Reasons and Issues

Mr. Bob Grossman will focus on the growth in transactions, particularly some of smaller ones in the BioMed and Agbio industries.  He will share his thoughts on reasons and discuss certain issues that arise from his point of view.

רוברט גרוסמן

Robert L. Grossman

Shareholder; Co-Chair Greenberg Traurig, Israel Practice

Bob Grossman began practicing securities, M&A and corporate law in the firm's Miami office in 1982. With wide-ranging experience taking companies public, acquiring and selling companies, and as a business advisor, Bob brings a practical business-oriented approach to his clients' problems, focusing on accomplishing his clients' objectives effectively and efficiently. He has represented a diverse collection of public and private companies, including companies in the medical device, pharmaceutical, biotechnology, health care, energy and natural resources, technology and software, and communications industries.

Bob is the Co-Chair of the firm's Israel Practice and is a frequent business visitor to Israel. In addition to representing Israeli companies, the firm's Israel Practice Group provides assistance to Israeli and U.S. companies through introductions to strategic partners. Greenberg Traurig's broad client base and network of offices and other resources are significant components of this process.

 

ברי שינדלר

Barry J. Schindler

Shareholder; Co-Chair, Global Patent Prosecution Group

Barry J. Schindler is Co-Chair of the firm's Global Patent Prosecution Group and a Shareholder in the Intellectual Property & Technology Practice. Barry has more than twenty years of legal experience in intellectual property law, including multidisciplinary litigation experience. He has helped companies of all sizes build and manage significant patent portfolios, develop in-house procedures and formulate intellectual property strategies. He positions clients to gain a competitive advantage by identifying patentable subject matter and drafting claims in such a way that infringement becomes possible to prove.


Barry has wide-ranging experience in business methodology, a rapidly emerging area of intellectual property, and has provided counsel to some of the world's most innovative corporations. These include a pre-eminent financial services organization, leading financial trading organizations, numerous leading health organizations, search engine organizations, media companies and other financial institutions. He lectures widely on business methods patents.